Teosyal RHA 2, 3, 4: Dynamic Strength for Natural Expression

Q: What is Teosyal RHA technology and how does it differ from standard HA fillers?

RHA technology preserves more of hyaluronic acid's natural polymer structure during crosslinking, producing gels that deform and recover under mechanical stress. This allows the filler to adapt to facial movement rather than resist it, unlike more extensively modified standard HA fillers.

Q: What is the difference between Teosyal RHA 2, RHA 3, and RHA 4?

RHA 2 offers the highest stretch for superficial-to-mid dermal placement in highly mobile areas. RHA 3 offers a balanced profile for mid-to-deep dermal injection. RHA 4 provides the greatest strength and volumizing capacity for deep dermal to subcutaneous placement in deeper folds and dynamic areas like the cheeks.

Q: What are Teosyal RHA fillers FDA-approved for?

RHA 2 and RHA 3 are FDA-approved for correction of moderate to severe dynamic facial wrinkles and folds in adults 22 and older. RHA 4 shares this indication and is also approved for deep injection to correct dynamic areas including the cheeks and facial contours.

Q: Can Teosyal RHA fillers be dissolved?

Yes. All Teosyal RHA products are HA-based and can be dissolved with hyaluronidase. Hyaluronidase must be immediately available at every RHA filler injection session.

Q: Which Teosyal RHA product is best for nasolabial folds?

RHA 3 suits moderate nasolabial folds with mid-to-deep dermal placement. RHA 4 is appropriate for deeper folds or where additional volume is needed. RHA 2 may be used for lighter perioral lines where maximum flexibility is the priority.

Doris Dermal Fillers April 28, 2025

Achieving facial rejuvenation that integrates with natural expression is a core goal in modern aesthetics. Patients increasingly seek treatments that soften wrinkles without producing a frozen or unnatural appearance — particularly in highly mobile facial zones. The Teosyal RHA® line of hyaluronic acid fillers, developed by Teoxane Laboratories, was specifically engineered to meet this challenge. Utilizing Resilient Hyaluronic Acid (RHA) technology, these dermal fillers are designed to adapt to facial dynamics while providing correction of dynamic wrinkles and folds.

This article covers the science behind RHA technology and provides a clinical comparison of the three core products: Teosyal RHA® 2, RHA® 3, and RHA® 4.

Understanding RHA® Technology

RHA stands for Resilient Hyaluronic Acid. The manufacturing process behind the RHA line is designed to preserve more of hyaluronic acid’s natural polymer structure compared to standard crosslinking processes. Traditional HA crosslinking modifies the HA chains more extensively to achieve stability, which can reduce the gel’s ability to deform and recover under mechanical stress. RHA technology retains more of the native HA structure, producing gels with two key properties:

Stretch — the ability to deform and extend with facial movements such as smiling, speaking, and squinting, then return to position
Strength — the ability to resist stress and maintain structural support even during movement

The clinical significance is that RHA fillers integrate and move synergistically with surrounding facial tissue. This allows correction of dynamic wrinkles and folds while maintaining a natural appearance during animation — a meaningful advantage over standard HA fillers in high-mobility zones.

Teosyal RHA® 2, RHA® 3, and RHA® 4: Product Overview

The RHA collection offers a graduated spectrum of products, each calibrated with different degrees of stretch and strength to suit varying clinical needs and injection depths. All formulations available in the US contain lidocaine for patient comfort. Each product has received US FDA approval with an age indication of 22 years and older.

Teosyal RHA® 2

Position in range — the most flexible formulation within the core RHA group, offering the highest stretch and lowest structural resistance
Properties — designed for superficial to mid-dermal placement, integrating smoothly into areas requiring significant mobility
FDA indication — correction of moderate to severe dynamic facial wrinkles and folds, including nasolabial folds, in adults aged 22 and older. Also used by practitioners for moderate dynamic lines including perioral and radial cheek lines where flexibility is the primary requirement
Clinical use — best suited to dynamic lines in areas of extreme mobility where maximum adaptability to movement takes priority over structural support

Teosyal RHA® 3

Position in range — balanced profile providing both good stretch and moderate dynamic strength; the most versatile product in the range for common mid-face indications
Properties — suitable for mid-to-deep dermal injection; more supportive than RHA 2 while retaining excellent flexibility
FDA indication — correction of moderate to severe dynamic facial wrinkles and folds, including nasolabial folds, in adults aged 22 and older
Clinical use — widely used for moderate to deeper dynamic folds requiring both structural support and movement adaptability, including nasolabial folds and oral commissures

Teosyal RHA® 4

Position in range — provides the greatest dynamic strength and structural support within this trio while still maintaining resilience under movement
Properties — designed for deep dermal to subcutaneous placement; provides robust support that adapts to facial movement
FDA indication — correction of moderate to severe dynamic facial wrinkles and folds including nasolabial folds, and injection in the deep dermis to subcutaneous tissue for dynamic areas such as cheeks and contours, in adults aged 22 and older
Clinical use — appropriate for deeper dynamic folds requiring significant volume and structural support, and for providing contour and volume in dynamic areas such as the cheeks where both support and movement adaptability are needed

Comparative Overview and Product Selection

The RHA 2, 3, and 4 products form a graduated series, allowing precise product-indication matching across a range of clinical needs:

Stretch-to-strength spectrum — RHA 2 offers maximum stretch with lower structural resistance; RHA 3 offers a balanced profile; RHA 4 provides the highest strength and structural support while retaining resilience
Wrinkle and fold depth — superficial to moderate concerns suit RHA 2; moderate to deep folds suit RHA 3; deep folds and volume loss suit RHA 4
Area dynamism — zones with extreme mobility favor RHA 2 or RHA 3; areas requiring more structural support during movement benefit from RHA 4
Volume requirement — RHA 4 provides the greatest volumizing capacity within this group and is the appropriate choice when meaningful volume restoration is required alongside dynamic correction
Injection plane — superficial to mid-dermis for RHA 2; mid-to-deep dermis for RHA 3; deep dermis to subcutaneous for RHA 4. Matching product to intended anatomical depth is essential for optimal integration and natural movement

Administration Considerations

Maximizing the clinical benefit of RHA fillers requires attention to technique. Accurate placement within the intended tissue plane is essential — it is this correct anatomical positioning that allows the gel to integrate and move naturally with surrounding tissue. The dynamic properties of RHA products are only fully expressed when placed at the appropriate depth.

Overcorrection should be avoided. The goal is natural enhancement that respects and adapts to facial dynamics, not static volume addition. Thorough pre-treatment assessment including observation of dynamic facial expressions helps guide appropriate product selection and injection planning.

Safety Profile and Contraindications

Common adverse events with RHA fillers are consistent with the broader HA filler category: temporary bruising, swelling, redness, and tenderness at the injection site. These are typically mild and self-limiting, resolving within a few days to one week.

Contraindications include known hypersensitivity to hyaluronic acid or any product component, active infection or inflammation at the intended injection site, and pregnancy or breastfeeding. Patients with a history of severe allergic reactions or anaphylaxis require careful screening before treatment. A thorough medical history is required before proceeding with any RHA filler injection.

Vascular occlusion remains the most serious complication of any dermal filler injection. Current guidance from major aesthetic medicine societies does not support mandatory aspiration as a reliable standalone safety measure. Primary vascular safety relies on slow injection speed, low injection pressure, small bolus volumes, and thorough knowledge of facial vascular anatomy. Hyaluronidase must be immediately available at every RHA filler session — all RHA products are HA-based and reversible with hyaluronidase. Practitioners must be trained in vascular occlusion recognition and emergency management before treating patients with any injectable filler.

Practitioners must consult the specific US Prescribing Information (IFU) provided for each RHA product before use. Each product has its own dosing guidance, reconstitution instructions, and safety information that must be reviewed prior to administration.

Sourcing Authentic Teosyal RHA® Fillers

Product authenticity is a non-negotiable component of patient safety and predictable clinical performance with RHA fillers. Counterfeit or improperly stored HA products carry serious risks including unpredictable potency, contamination, and unexpected adverse events.

Health Supplies Plus supplies authentic Teosyal RHA® fillers to licensed medical professionals at wholesale pricing, with verified supply chain traceability. Register your practice for free to complete one-time license verification and access our full dermal fillers catalog.

Conclusion

The Teosyal RHA® collection provides a clinically differentiated option for practitioners treating dynamic wrinkles and folds in high-mobility facial zones. Its Resilient Hyaluronic Acid technology offers a meaningful balance of stretch and structural support that standard crosslinked HA fillers do not replicate. The graduated properties of RHA 2, 3, and 4 allow precise product-indication matching — from superficial dynamic lines requiring maximum flexibility through to deeper folds and cheek contouring requiring volume and structural support with movement adaptability.

Discover the Teosyal RHA® Collection at Health Supplies Plus

Teosyal RHA® Frequently Asked Questions

1. What is Teosyal RHA technology and how does it differ from standard HA fillers?

RHA (Resilient Hyaluronic Acid) technology preserves more of hyaluronic acid’s natural polymer structure during crosslinking compared to traditional manufacturing processes. This produces gels that deform and recover under mechanical stress — adapting to facial movement rather than resisting it. Standard HA fillers are more extensively modified during crosslinking, which can reduce their ability to integrate naturally with dynamic facial tissue.

2. What is the difference between Teosyal RHA 2, RHA 3, and RHA 4?

The three products form a graduated spectrum of stretch and strength. RHA 2 offers the highest stretch and lowest structural resistance, suited to superficial-to-mid dermal placement in highly mobile areas. RHA 3 offers a balanced profile for mid-to-deep dermal injection in moderate to deeper dynamic folds. RHA 4 provides the greatest strength and volumizing capacity, designed for deep dermal to subcutaneous placement in deeper folds and dynamic areas like the cheeks.

3. What are Teosyal RHA fillers FDA-approved for?

RHA 2 and RHA 3 are FDA-approved for the correction of moderate to severe dynamic facial wrinkles and folds, including nasolabial folds, in adults aged 22 and older. RHA 4 shares this indication and is also approved for deep dermal to subcutaneous injection to correct dynamic areas such as the cheeks and facial contours in the same patient population.

4. Why is the minimum age indication 22 for Teosyal RHA products?

The FDA age indication of 22 years and older is specific to the US approval for these products, based on the clinical trial populations used to support their approval. Practitioners should adhere to this indication when treating patients in the US.

5. Which Teosyal RHA product is best for nasolabial folds?

Both RHA 3 and RHA 4 are appropriate for nasolabial folds depending on depth and severity. RHA 3 suits moderate folds with mid-to-deep dermal placement. RHA 4 is more appropriate for deeper, more pronounced folds or where additional volume is required alongside structural support. RHA 2 may be used for lighter perioral lines where maximum flexibility is the priority.

6. Can Teosyal RHA 4 be used for cheek augmentation?

Yes. RHA 4 is FDA-approved for injection in the deep dermis to subcutaneous tissue to correct moderate to severe dynamic areas including cheeks and contours. Its higher strength and volumizing capacity make it the appropriate RHA product for cheek treatment, where structural support during facial movement is required alongside volume restoration.

7. Do Teosyal RHA fillers contain lidocaine?

Yes. US formulations of Teosyal RHA 2, RHA 3, and RHA 4 contain lidocaine for patient comfort during injection. This reduces injection discomfort without requiring a separate anesthetic step, which is a practical clinical advantage in sensitive treatment areas.

8. Can Teosyal RHA fillers be dissolved?

Yes. All Teosyal RHA products are hyaluronic acid-based and can be dissolved with hyaluronidase. This is essential in the event of vascular occlusion and can also be used for overcorrection or patient dissatisfaction. Hyaluronidase must be immediately available at every RHA filler injection session.

9. What are the contraindications for Teosyal RHA fillers?

Contraindications include known hypersensitivity to hyaluronic acid or any product component, active infection or inflammation at the injection site, and pregnancy or breastfeeding. Patients with a history of severe allergic reactions or anaphylaxis require careful screening. A thorough medical history must be completed before treatment. Refer to the product-specific IFU for the full contraindication list.

10. How does Teosyal RHA compare to Juvederm Vycross products for dynamic areas?

Both RHA and Vycross technologies produce high-quality HA gels suited to different indications. Vycross products (Voluma, Volift, Volbella) are differentiated by their high cohesivity and long duration, with G’ values calibrated for specific depths and indications. RHA products are specifically designed to optimize dynamic behavior — deforming and recovering under facial movement — which is their primary clinical differentiator. In highly mobile facial zones, RHA’s stretch properties may produce more natural movement behavior than standard cohesive gels. Product selection depends on the indication, injection depth, and the practitioner’s clinical assessment of each patient.

11. Where can licensed practices buy Teosyal RHA fillers wholesale?

Licensed medical professionals can purchase authentic Teosyal RHA 2, RHA 3, and RHA 4 at wholesale pricing through Health Supplies Plus. Registration is free and requires one-time license verification. Once approved, verified accounts have access to the full Teosyal range and broader dermal filler catalog with tiered volume savings.

Doris

About the Author: Doris Dickson is a specialist writer for Health Supplies Plus, focusing on the aesthetic medicine industry. She diligently researches cosmetic treatments and products to provide clear, concise information relevant to licensed medical professionals. Her work supports Health Supplies Plus’s commitment to being a reliable informational resource and trusted supplier for the aesthetic community.

Disclaimer: The content provided in this article is intended for informational purposes only and is directed towards licensed medical professionals. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment, nor does it constitute an endorsement of any specific product or technique. Practitioners must rely on their own professional judgment, clinical experience, and knowledge of patient needs, and should always consult the full product prescribing information and relevant clinical guidelines before use. Health Supplies Plus does not provide medical advice.